Synta's rise is just starting....IMO
Other than some profit-taking (or macro factors--fiscal cliff, etc), I see no reason why we wont continue this ascent into the results of the Chiara (ALK+ NSCLC) and ENCHANT (Breast Ca) trials early next year.. right into the final Galaxy 1 results...just my opinion.
I see no negatives at all to stop this train at this time...